Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion

Endocrine. 2021 Jul;73(1):223-225. doi: 10.1007/s12020-021-02666-5. Epub 2021 Mar 2.

¹ Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. a.anastasilakis@gmail.com.
² First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
⁴ Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
⁵ Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.

No abstract available

Publication types